Stream 3, Session 3: Post market surveillance
Time |
Session details |
14:15 |
Welcome address |
14:20 |
Post market surveillance |
14:40 |
AI in Flight: Navagating the path to safe landing or risking a crash? Artificial intelligence (AI) has shown promise for use in a range of healthcare tasks such as diagnosis, prognosis, and even drug dosing. While evidence suggests that AI can enhance or even exceed clinician accuracy in specific tasks, much of this evidence is retrospective, with limited prospective data from studies such as randomised controlled trials. Despite this, there has been an exponential increase in the number of commercially available AI enabled medical devices. Ensuring the safety of clinical AI technologies requires rigorous post-market surveillance, a process crucial for monitoring and mitigating risks. This session explores algorithmic auditing in addition to adverse event reporting across clinical trials and real-world settings, emphasizing the importance of post-market surveillance. A focus on the Medical Algorithmic Audit framework will provide a blueprint for AI safety monitoring, alongside insights into stakeholder views on surveillance, outlining essential tools for ensuring ongoing safety in AI deployment. |
15:00 |
Best practive for evaluating AI for screening: |
15:20 |
Panel discussion: |
15:45 |
Session ends |
Programme subject to change
To discover more about our speakers participating at our AI Global Conference click here.
Speakers
Dr Geraldine Dean MD MSc MRCS FRCR

Dr Aditya Kale

Professor Alicja Rudnicka
